Cepheid this week named Robert Kwiatkowski as its VP of infectious disease research and development, while HTG hired a new chief legal counsel, and BioNanomatrix named two new execs, and more.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.